Articles liés à Development Of Potential Reverse Transcriptase Inhibitors:...

Development Of Potential Reverse Transcriptase Inhibitors: Using Molecular Modeling Studies - Couverture souple

Bhandari, Shashikant; Pawar, Vidya

 
9783845478371: Development Of Potential Reverse Transcriptase Inhibitors: Using Molecular Modeling Studies

Synopsis

Non-nucleoside reverse transcriptase inhibitors (NNRTI) has a definitive role and most commonly used in treatment of HIV infection. NNRTI act by binding to specific binding site (non-nucleoside binding pocket-NNBP) in reverse transcriptase (RT) enzyme. With the objective of developing efficient NNRTI, we have designed various Isatin analogs for effective treatment of AIDS and were subjected to molecular docking studies on five different crystal structures of RT complexed with five different ligands Nevirapine, Delaviridine, Efavirenz, Etravirine, and Rilpivirine. Combined dock-score of compound N21, N11, N23 was found to be comparable with standards indicated that Isatin analogs have good binding affinity for NNBP. Docking results suggested that these types of compounds could be binding in the NNRTI binding site in a similar mode to a known non-nucleoside inhibitors. ADME properties of Isatin analogs were also analyzed using Qikprop 2.5 tool of Schrodinger software. In the present thesis applications of new computational tools for drug discovery are explored and the details of methodology, results, discussion and conclusions derived are presented.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.

Présentation de l'éditeur

Non-nucleoside reverse transcriptase inhibitors (NNRTI) has a definitive role and most commonly used in treatment of HIV infection. NNRTI act by binding to specific binding site (non-nucleoside binding pocket-NNBP) in reverse transcriptase (RT) enzyme. With the objective of developing efficient NNRTI, we have designed various Isatin analogs for effective treatment of AIDS and were subjected to molecular docking studies on five different crystal structures of RT complexed with five different ligands Nevirapine, Delaviridine, Efavirenz, Etravirine, and Rilpivirine. Combined dock-score of compound N21, N11, N23 was found to be comparable with standards indicated that Isatin analogs have good binding affinity for NNBP. Docking results suggested that these types of compounds could be binding in the NNRTI binding site in a similar mode to a known non-nucleoside inhibitors. ADME properties of Isatin analogs were also analyzed using Qikprop 2.5 tool of Schrodinger software. In the present thesis applications of new computational tools for drug discovery are explored and the details of methodology, results, discussion and conclusions derived are presented.

Biographie de l'auteur

M.Pharm.Ph.D., Designation-Professor,Reasearch interest drug design and development of anti HIV,anticancer, CVS,molecular modeling, QSAR, docking,ADMET prediction,Anti-inflammatory agents. 15 International research papers, 5 conferences.2 Books. guided 22 m.pharm..4 Ph.D.projects.Taught medicinal chem.Total impact factor 20.h index-5 citations 50

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Vos droits au titre de la garantie légale : Chaque consommateur de l'UE bénéficie d'au moins deux ans de protection au titre de la garantie légale pour tout bien de consommation vendu dans l'UE. Voir plus